|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 81 - 90 of 657:
FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
A top regenerative medicine company, Aastrom Biosciences, Inc. (Nasdaq:ASTM), today reported that the clinical hold from the Company's U.S. Phase II I...
Alcon Gets FDA Approval for Its Aspheric AcrySof IQ Toric Intraocular Lens
Alcon, a company engaged in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof IQ ...
Competitive Technologies Receives FDA Authorization for Sales of Pain Therapy Medical Device
Competitive Technologies, announced that the US Federal Drug Administration (FDA) has issued a 501(k) letter of authorization allowing US sales of CTT...
FDA Releases Names of Drugs Now Available as Money-Saving Generics
FACT is a not-for-profit association which was founded in 1984 and which provides a variety of benefits -- ranging from medical insurance and dental c...
Bard Receives FDA Approval for the LifeStent Vascular Stent
C. R. Bard announced that it has received Pre-Market Approval (PMA) from the United States Food and Drug Administration to market the LifeStent FlexSt...
FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
CryoLife, a biomaterials, medical device and tissue processing company, announced today that the U.S. Food and Drug Administration (FDA) has cleared a...
Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Upsher-Smith Laboratories announced the publication of results of a Phase III study demonstrating that Divigel low-dose transdermal estradiol gel 0.1%...
Suntron Corporation Announces FDA Quality Certification at Sugar Land, TX Facility
Suntron Corporation, provider of integrated electronic manufacturing solutions (EMS) and Commercial Off The Shelf Technology (COTS) design solutions w...
FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events
The first data offering health care professionals a better look into the genetic basis of certain types of adverse drug events was released today by t...
FDA Approves First Ablation Catheters for the Treatment of Atrial Fibrillation
The U.S. Food and Drug Administration today approved the first ablation catheters for the treatment of atrial fibrillation (uncoordinated contraction... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |